We found that Wag31 interacts with AccA3.
Lower expression of Wag31 results in higher lipid permeability.
Lower expression of Wag31 results in lower resistance to lipophilic drugs.
Overexpression of AccA3 results in lower lipid permeability.
Overexpression of AccA3 results in higher resistance to lipophilic drugs.